Evidence map›Paper›PMID 35832786›Full record

ArticleJournal of diabetes research2022

Determinants of Poor Treatment Adherence among Patients with Type 2 Diabetes and Limited Health Literacy: A Scoping Review.

Nasrin Pourhabibi, Bahram Mohebbi, Roya Sadeghi, Elham Shakibazadeh, Mojgan Sanjari, Azar Tol, Mehdi Yaseri

Registry-linked trialAbstract readScoping Review
In one paragraph

Article in Journal of diabetes research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06501456 (Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06501456 completednot on this map

Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic: Cross-sectional Studio.

TypeobservationalSponsorHospital Italiano de Buenos AiresRan2020 to 2020Enrolled46ConditionsNo-Show Patients, Therapeutic Adherence and Compliance, Type 2 Diabetes Mellitus, COVID-19
3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nasrin PourhabibiSchool of Public Health Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-8342-0064
Bahram MohebbiCardiovascular Intervention Research Center, Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-9207-6971
Roya SadeghiDepartment of Health Promotion and Education, School of Public Health Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-4290-0950
Elham ShakibazadehDepartment of Health Promotion and Education, School of Public Health Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-1320-2133
Mojgan SanjariDepartment of Internal Medicine, School of Medicine Endocrinology and Metabolism Research Center Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0002-3402-4401
Azar TolDepartment of Health Education and Health Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-9225-941X
Mehdi YaseriDepartment of Epidemiology and Biostatistics, School of Public Health Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-4066-873X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevention of complications and successful control of diabetes require preventive and therapeutic measures. Patients' nonadherence to medication and diet regimens and healthcare protocols is associated with significant therapeutic and economic consequences. The present scoping review aims to identify determinants of poor treatment adherence among patients with type 2 diabetes and limited health literacy in 2021. This scoping review was conducted in five stages: designing a research question, searching and extracting related studies, selecting related studies, tabulating information, and reporting results. Data were collected from six foreign electronic databases (Embase, Science Direct, PubMed, Google Scholar, Scopus, and Web of Science) and four Iranian electronic databases (MagIran, SID, IranDoc, and IranMedex) using keywords "Type 2 diabetes", "barriers", "treatment", "medication", "adherence", "non-adherence", "limited adherence", and "limited health literacy" from January 2010 to November 2021. From an initial 146 articles, 18 articles were eligible for review. Eighteen studies involving 3925 patients with T2DM from eight countries were included. The prevalence of nonadherence ranged from 42% to 74.3%. Barriers to treatment adherence, which were common among the articles, included economic problems, poor communication with healthcare team, lack of family support, lack of knowledge, misconceptions, and limited health literacy. The results of the present study provided modifiable and nonmodifiable factors affecting treatment adherence among patients with type 2 diabetes. Modifiable factors are essential by performing appropriate interventions with the target group and health professionals.

Indexed as

Diabetes Mellitus, Type 2Health LiteracyClinical ProtocolsHumansIranMedication AdherencePatient Compliance

Identifiers

PMID35832786
PMCPMC9273343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.